Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis

Kosaku Nanki, Shinta Mizuno, Katsuyoshi Matsuoka, Keiko Ono, Shinya Sugimoto, Hiroki Kiyohara, Mari Arai, Moeko Nakashima, Kozue Takeshita, Keiichiro Saigusa, Mitsutoshi Senoh, Tadashi Fukuda, Makoto Naganuma, Haru Kato, Wataru Suda, Masahira Hattori, Takanori Kanai

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

Original languageEnglish
Pages (from-to)142-146
Number of pages5
JournalIntestinal Research
Volume16
Issue number1
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Clostridium Infections
Clostridium difficile
Ulcerative Colitis
Dysbiosis
Recurrence
Microbiota
Colonoscopy
Fecal Microbiota Transplantation
Diarrhea
Therapeutics
Gastrointestinal Microbiome

Keywords

  • Clostridium difficile
  • Colitis
  • Fecal microbiota transplantation
  • Ulcerative

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis. / Nanki, Kosaku; Mizuno, Shinta; Matsuoka, Katsuyoshi; Ono, Keiko; Sugimoto, Shinya; Kiyohara, Hiroki; Arai, Mari; Nakashima, Moeko; Takeshita, Kozue; Saigusa, Keiichiro; Senoh, Mitsutoshi; Fukuda, Tadashi; Naganuma, Makoto; Kato, Haru; Suda, Wataru; Hattori, Masahira; Kanai, Takanori.

In: Intestinal Research, Vol. 16, No. 1, 01.01.2018, p. 142-146.

Research output: Contribution to journalArticle

Nanki, K, Mizuno, S, Matsuoka, K, Ono, K, Sugimoto, S, Kiyohara, H, Arai, M, Nakashima, M, Takeshita, K, Saigusa, K, Senoh, M, Fukuda, T, Naganuma, M, Kato, H, Suda, W, Hattori, M & Kanai, T 2018, 'Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis', Intestinal Research, vol. 16, no. 1, pp. 142-146. https://doi.org/10.5217/ir.2018.16.1.142
Nanki, Kosaku ; Mizuno, Shinta ; Matsuoka, Katsuyoshi ; Ono, Keiko ; Sugimoto, Shinya ; Kiyohara, Hiroki ; Arai, Mari ; Nakashima, Moeko ; Takeshita, Kozue ; Saigusa, Keiichiro ; Senoh, Mitsutoshi ; Fukuda, Tadashi ; Naganuma, Makoto ; Kato, Haru ; Suda, Wataru ; Hattori, Masahira ; Kanai, Takanori. / Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis. In: Intestinal Research. 2018 ; Vol. 16, No. 1. pp. 142-146.
@article{370c35a093dc4cfc85fd5e6a5b09db32,
title = "Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis",
abstract = "Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.",
keywords = "Clostridium difficile, Colitis, Fecal microbiota transplantation, Ulcerative",
author = "Kosaku Nanki and Shinta Mizuno and Katsuyoshi Matsuoka and Keiko Ono and Shinya Sugimoto and Hiroki Kiyohara and Mari Arai and Moeko Nakashima and Kozue Takeshita and Keiichiro Saigusa and Mitsutoshi Senoh and Tadashi Fukuda and Makoto Naganuma and Haru Kato and Wataru Suda and Masahira Hattori and Takanori Kanai",
year = "2018",
month = "1",
day = "1",
doi = "10.5217/ir.2018.16.1.142",
language = "English",
volume = "16",
pages = "142--146",
journal = "Intestinal Research",
issn = "1598-9100",
publisher = "Korean Association for the Study of Intestinal Diseases",
number = "1",

}

TY - JOUR

T1 - Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis

AU - Nanki, Kosaku

AU - Mizuno, Shinta

AU - Matsuoka, Katsuyoshi

AU - Ono, Keiko

AU - Sugimoto, Shinya

AU - Kiyohara, Hiroki

AU - Arai, Mari

AU - Nakashima, Moeko

AU - Takeshita, Kozue

AU - Saigusa, Keiichiro

AU - Senoh, Mitsutoshi

AU - Fukuda, Tadashi

AU - Naganuma, Makoto

AU - Kato, Haru

AU - Suda, Wataru

AU - Hattori, Masahira

AU - Kanai, Takanori

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

AB - Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.

KW - Clostridium difficile

KW - Colitis

KW - Fecal microbiota transplantation

KW - Ulcerative

UR - http://www.scopus.com/inward/record.url?scp=85040679999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040679999&partnerID=8YFLogxK

U2 - 10.5217/ir.2018.16.1.142

DO - 10.5217/ir.2018.16.1.142

M3 - Article

VL - 16

SP - 142

EP - 146

JO - Intestinal Research

JF - Intestinal Research

SN - 1598-9100

IS - 1

ER -